| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |